Led · Equity · Sep 2025

Founded in 2019, EvoluteIQ develops the EIQ platform, which leverages an Agentic Mesh Architecture and an AI Workbench to deliver end-to-end automation across banking, insurance, healthcare, telecommunications and manufacturing. The platform combines low-code/no-code/pro-code tooling with native generative-AI decisioning, eliminating the need for multiple point solutions. Enterprises use EIQ to design, deploy and scale AI-enabled business processes more quickly, securely and cost-effectively, and several Fortune 500 companies have already adopted the technology to boost operational resilience. EvoluteIQ positions its offering as a shift from reactive automation to proactive, intelligent orchestration through agentic AI models. The company intends to use its newly raised capital to accelerate global expansion and solidify its leadership in enterprise-grade agentic AI automation. No revenue or user figures were disclosed in the article, but the firm emphasizes outcome-driven models as a competitive differentiator.

Led · Series B · Sep 2024

BlackCloak is an Orlando, FL–based company that specializes in digital executive protection and personal cybersecurity for corporate executives, high-net-worth individuals, and family offices. Its BlackCloak Concierge Cybersecurity & Privacy™ platform helps shield clients from threats such as deepfakes, advanced social engineering, cyber-extortion, doxxing, and physical threats. The company is used by Fortune 500 and Fortune 50 companies, the world’s largest financial institutions, prominent public officials, and talent management firms in the entertainment industry. Led by CEO and founder Dr. Chris Pierson, BlackCloak markets itself as a trusted solution for high-profile clients across industries. The company raised $17M in a Series B to support product development and protection services; the round brought total funding to $30M. BlackCloak says it will use the proceeds to enhance its personal cybersecurity platform for executives, high-net-worth individuals, and family offices. BlackCloak provides a Concierge Cybersecurity & Privacy™ platform that protects corporate executives and high‑profile individuals from cybersecurity, privacy, financial, and reputational risks. The holistic solution includes mobile and desktop apps as well as concierge support. Led by CEO and founder Dr. Chris Pierson, the company published 2020 research showing 40% of executives were already compromised, 70% had exposed passwords on the deep/dark web, and 87% had no security installed on personal devices. BlackCloak is used by Fortune 500 companies across industries. The company intends to use the funds to expand its proprietary technology offering in cybersecurity and privacy, deepen relationships with members, and grow its team and sales operations. BlackCloak is a US creator of a cybersecurity platform that provides Concierge Cybersecurity services to high-net-worth individuals, high-profile persons, and corporate executives. The platform protects clients in their personal lives to mitigate hacking, financial, and reputational risks. The company is led by Dr. Chris Pierson, Founder and CEO. BlackCloak raised $1.9M in funding from DataTribe. It intends to use the funds to strengthen its concierge cybersecurity platform and expand its presence within key sectors where cybercrime losses and intellectual theft are on the rise. As part of the investment, John Funge, Chief Product Officer at DataTribe, will join BlackCloak’s board of directors.

Led · Series B · Aug 2024

ModelOp provides AI governance software for enterprises and is led by CEO Pete Foley. Its platform safeguards enterprise AI initiatives, including generative AI, large language models, in-house, third-party, and embedded systems, without stifling innovation. Through automation and integrations, ModelOp helps enterprises quickly address critical governance and scale challenges. The company aims to protect and improve the transformational value of enterprise AI, resulting in effective and responsible AI systems. ModelOp plans to use the new funding to accelerate product innovation and build enterprise expertise. The company is based in Chicago, Illinois. ModelOp provides ModelOp Center, a software platform that automates model deployment, monitoring and governance and enables organizations to put models into production faster with control, visibility and auditability. The company announced general availability of ModelOp Center Version 2. Customers include five of the top 10 largest financial institutions as well as Fortune 500 manufacturers, insurers and credit bureaus. Led by CEO Pete Foley, ModelOp recently expanded its executive team with hires including a CFO and VPs of software engineering and marketing. The company closed a $6M Series A to support demand and to add engineering, services, sales, operations and customer success headcount. The business serves major enterprises and is focused on scaling its platform and go-to-market.

Led · Series C · Sep 2023

Virtual Incision is developing MIRA, a compact, drape- and dock-free miniaturized robotic-assisted surgery system designed to deliver internal triangulation and full wrist articulation inside the body. The device is lightweight and portable so it can be used in any operating room without a dedicated mainframe room. MIRA is an investigational device; the company completed an IDE clinical study for bowel resection and has a De Novo request under substantive FDA review. Virtual Incision holds over two hundred patents and patent applications and is focused on expanding access to RAS in routine and high-volume procedures, including outpatient and ambulatory settings. The company plans a limited launch of MIRA across select U.S. centers if marketing authorization is granted and will run a gynecologic clinical study planned for 2024. It is also developing a smaller minibot iteration with a first-in-human clinical study expected next year and will support a NASA–University of Nebraska–Lincoln collaboration to demonstrate telesurgery on the ISS. Virtual Incision is developing the MIRA (“miniaturized in vivo robotic assistant”) Surgical Platform, a small self-contained device inserted through a single midline umbilical incision to support multi-quadrant abdominal laparoscopic procedures. The technology is designed to work with existing minimally invasive tools and techniques, avoid the need for a dedicated operating room or specialized infrastructure, and to be significantly less expensive than existing robotic systems. The company recently reported the world’s first surgery using MIRA—a robotically assisted right hemicolectomy—performed under an FDA Investigational Device Exemption as part of a clinical study at a limited number of U.S. hospitals. Virtual Incision is developing a family of mini-robots for additional procedures including hernia repair, gallbladder removal, hysterectomy, and sleeve gastrectomy. The company holds foundational intellectual property with more than 200 patents and applications. Virtual Incision is headquartered in Lincoln, Neb., and recently raised financing to advance its regulatory, clinical, commercialization, and R&D programs. Virtual Incision develops the MIRA (“miniaturized in vivo robotic assistant”), a two-pound robotic platform for minimally invasive abdominal surgery. The company emphasizes MIRA’s portability and affordability compared with many existing, much larger surgical robots. VIC positions the device to expand access to minimally invasive procedures and improve patient outcomes. CEO John Murphy said the company believes the portable and affordable abdominal robot can bring these benefits to many more patients. The company plans an IDE clinical study with the FDA as the critical next step and will use recent funding to ready the device for commercialization. The latest financing brings the company’s total funding to $51 million. Virtual Incision is developing a small, self-contained robotically assisted surgical device (RASD) designed to be inserted through an umbilical incision to perform multi-quadrant abdominal procedures. The platform leverages artificial intelligence and machine learning to track and guide instrument usage and includes the company’s robotic flex tip laparoscope controlled by the surgeon. The company emphasizes compatibility with existing surgical tools and techniques and a design that does not require a dedicated operating room or specialized infrastructure. Virtual Incision says its technology has foundational intellectual property including over 140 patents and applications and was used outside the U.S. in 2016 in a safety and feasibility colon resection trial. The company is a University of Nebraska spinout based in Lincoln, Nebraska, and Pleasanton, California, and its devices are investigational and not commercially available. Virtual Incision recently raised an $18 million Series B to support development toward FDA 510(k) submission and near-term milestones including FDA clearance, U.S. team building, a surgeon training center at UNMC, and a China joint venture. Virtual Incision develops a first-of-its-kind miniaturized robotically assisted surgical device designed to be inserted in its entirety through a single abdominal incision to enable minimally invasive general surgery. The platform is designed to utilize existing tools and surgeon techniques, avoid dedicated operating-room infrastructure, and be significantly smaller and less expensive than current mainframe robotic systems. The company says the system could enable minimally invasive approaches to procedures that are typically performed open today, with potential to improve clinical outcomes and health-care costs. Its investigational device is supported by more than 90 pending and granted patents and 70 comparative medicine studies, and the technology is a spinout of the University of Nebraska. Virtual Incision plans to use the recently closed $11.2 million equity financing to fund a feasibility study of the robot for colon resection procedures. The device is not commercially available; the company is based in Lincoln, Neb. and Pleasanton, Calif.

Led · Series B · Aug 2023

Osano provides a privacy platform and suite of products to help organizations build, automate and scale privacy programs, with integrations for websites, Android and iOS. The platform uses AI to locate and classify protected information across data stores and offers tools for cookie consent and subject rights. Osano also offers regulatory guidance via a dedicated team of attorneys and provides frameworks to identify gaps and improve privacy programs. The company says it serves many industries, including financial services, e-commerce, healthcare, media, retail and CPG. Osano plans to use new funding to expand engineering, product development, sales, increase R&D investment and build a channel program. The startup reports more than 40,000 users and delivers over 1 billion cookie consent banners per month, and has raised $44.4 million in total capital to date. Osano is a software-as-a-service platform that helps companies monitor and manage their risk and compliance with privacy laws like Europe’s GDPR and California’s CCPA. The platform tracks changes to the rules and laws it covers to help customers avoid falling out of compliance and facing fines. Osano is rolling out an AI-powered data discovery tool to automatically find and classify dozens of types of personal and nonpersonal data. It offers integrations with dozens of apps and services, including AWS, Dropbox, Google and Oracle. The company plans to use new funding to double headcount with a focus on sales to meet growing demand. To date the startup has raised a total of $22.3 million, including a $5 million Series A in 2019. Osano is a risk and compliance startup offering a privacy platform to help businesses understand and address compliance with state and international privacy laws. One of its flagship features provides cookie and consent management on customer websites, allowing users to choose privacy settings in their own language. The turnkey platform is used by more than 750,000 companies — including some Fortune 500 companies — to secure over 3.5 million websites. The Austin, Texas-based company raised $5.4 million in a Series A led by LiveOak Venture Partners and Next Coast Ventures, bringing total capital raised to date to $8.4 million. Osano plans to use the new funds to further invest in research and development, marketing, and hiring to meet growing demand. Co-founder and CEO Arlo Gilbert said the company is moving quickly to add talent and deepen its position as a leading data privacy platform. Osano, founded in 2018 by Arlo Gilbert, builds tools to increase data-privacy transparency for consumers and businesses. Its core product, Privacy Monitor, is a free browser plugin (Chrome, Firefox, Safari) and a mobile app (Android, soon iOS) that analyzes thousands of online privacy policies and surfaces a proprietary privacy reputation score. The score reflects how companies collect, use, share and store data and whether they comply with regulations such as GDPR. The company emerged from stealth alongside the launch of Privacy Monitor and intends to use new funding to launch and expand adoption of its Privacy Monitor tools and privacy reputation scoring system. Osano operates as a B Corporation and positions purpose alongside profit in its business decisions. The company recently completed a seed financing to support product rollout and user growth.